Gujarat Exclusive >


Potential coronavirus drug ‘Remdesivir’ fails in Chinese trial

US-based Gilead Sciences’ Remdesivir, a potential antiviral drug to treat COVID-19 patients and is under several trials around the world, has reportedly failed to produce desired results during a Chinese trial study, the Financial Times reported on Thursday. Gilead’s shares fell on the results of the study and were down almost 5 per cent. Citing...